← Evidence map

ArticleCancer letters2025

Corrigendum to "Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations" [619 1 (2025) 217668 1-13].

Yasuaki Uemoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations" [619 1 (2025) 217668 1-13]. | OpenQuestion